Attendee’s Takeaways: 5th Clinical Trials Phase I & Phase IIA Summit
Wednesday March 13th, 2019
In this article, Moe Alsumidaie, MBA, MSF (Chief Data Scientist at Annex Clinical, and Editorial Advisory Board member/contributor to Applied Clinical Trials) discusses the following three subjects and how ExL’s conference explored them:
Adaptive design in protocol writing
Designing safer early phase studies
Monitoring oversight in early phase trials
For a more complete look at these topics and to learn more about our Clinical Trials Phase I & Phase IIA Summit, read the full article here!
The mission of the Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure their early stage clinical trials are executed on time and within budget while exploring how to leverage innovative approaches to managing clinical trials for all therapeutic areas.
For the Conference Documentation from ExL Events’ 5th Clinical Trials Phase I & Phase IIA Summit, click here!
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs